Company
Headquarters: Singapore, Singapore
Employees: 294
CEO: Dr. Teck Liang Beng
S$192.1 Million
SGD as of Dec. 1, 2022
US$142.3 Million
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Singapore Medical Group Limited operates medical clinics and provides general medical services in Singapore. The company operates through three segments: Health Business, Diagnostic & Aesthetics Business, and Others. The Health Business segment offers obstetrical and gynaecological services for the wellness of women; oncology services, including the prevention, diagnosis, and treatment of cancer, cancer screening and cancer genetic, and risk assessment; endocrinology services; general medicine and health screening services; cardiology services; and paediatrics services. The Diagnostic & Aesthetics Business segment provides radiology and diagnostic imaging services; refractive surgery services; dental services, including general dental services, prosthodontics, orthodontics, implant dentistry, oral surgery, and gum treatment; and aesthetics medicine services consisting of facial aesthetics, body aesthetics, facial and breast fillers, IPL, lasers, Botox, microdermabrasion minimally invasive Silhouette threadlift, VASER-assisted LipoSelection, and plastic surgery. The Others segment offers business consultancy and telemedicine services. It also offers breast related medical services; develops software/e-commerce applications for medical related services, as well as operates approximately 30 clinics. The company was incorporated in 2005 and is based in Singapore.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Singapore Medical Group Ltd has the following listings and related stock indices.
Stock: SGX: 5OT wb_incandescent